1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Europe Radiotherapy Market Outlook - Forecast (2014-2020)

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.

This report analyzes the markets for “Radiotherapy“. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance Europe (Germany, France, Italy, U.K. and Spain). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities.

This report provides:
- Market forecasts for a minimum of 5 years of all the mentioned segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Market share assessments of the top players along with strategic recommendations for the new entrants

Table Of Contents

Europe Radiotherapy Market Outlook - Forecast (2014-2020)
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.3.1 Strong Network of the major players
3.3.2 Wide range of product offerings
3.3.3 Increasing usage of Chocolate as a Functional Food
3.4 Market Constraints
3.4.1 Supply Dependency On West African Countries For Cocoa
3.4.2 Sluggish growth in Developed regions
3.4.3 Rapidly changing end user preferences

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Radiotherapy Market by Product Type
5.1 Non-Ionizing Radiation
5.2 Ionizing Radiation
5.3 Particle Radiation
5.4 Electron Beams
5.5 Proton Beams
5.6 Neutron Beams
5.7 Carbon Ions
5.8 Alpha and Beta Particles
5.9 Photon Radiations
5.10 Gamma Rays
5.11 X-rays

6 Radiotherapy Market by Technology
6.1 Intensity Modulated Radiation Therapy (IMRT)
6.2 3-D Conformal Radiotherapy (3D CRT)
6.3 Proton Beam Therapy
6.4 Stereotactic Technology
6.5 Tomotherapy
6.6 Adaptive Radiation Therapy
6.7 Systemic Radiation Therapy

7 Radiotherapy Market by Application
7.1 Lung Cancer
7.2 Colorectal Cancer
7.3 Prostate Cancer
7.4 Breast Cancer
7.5 Head and Neck Cancer
7.6 Brain Cancer
7.7 Spine Cancer
7.8 Cervical Cancer

8 Geographical Segmentation
8.1 Europe
8.1.1 Germany
8.1.2 France
8.1.3 Italy
8.1.4 UK
8.1.5 Spain

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions and Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Varian Medical Systems
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Siemens Healthcare
10.3 Nordion, Inc
10.4 IBA Group
10.5 GE Healthcare
10.6 Covidien, Plc
10.7 Cardinal Health, Inc.
10.8 Accuray, Inc.
10.9 ANSTO
10.10 C. R. Bard, Inc.
11 Appendix
12 Disclaimer

List of Exhibits
Table 1 Europe Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 2 Europe Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 3 Europe Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 4 Europe Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 5 Europe Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 6 Europe Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 7 Europe Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 8 Europe Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 9 Europe Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 10 Europe Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 11 Europe Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 12 Europe Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 13 Europe Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 14 Europe Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 15 Europe Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 16 Europe Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN) Germany
Table 17 Europe Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN) France
Table 18 Europe Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN) Italy
Table 19 Europe Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN) UK
Table 20 Europe Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN) Spain
Table 21 Europe Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 22 Europe Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 23 Europe Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 24 Europe Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 25 Europe Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 26 Europe Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 27 Europe Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 28 Europe Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 29 Europe Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 30 Europe Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 31 Germany Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 32 Germany Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 33 Germany Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 34 Germany Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 35 Germany Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 36 Germany Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 37 Germany Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 38 Germany Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 39 Germany Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 40 Germany Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 41 Germany Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 42 Germany Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 43 Germany Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 44 Germany Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 45 Germany Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 46 Germany Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 47 Germany Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 48 Germany Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 49 Germany Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 50 Germany Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 51 Germany Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 52 Germany Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 53 Germany Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 54 Germany Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 55 Germany Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 56 Germany Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 57 Germany Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 58 Germany Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 59 Germany Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 60 Germany Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 61 France Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 62 France Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 63 France Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 64 France Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 65 France Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 66 France Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 67 France Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 68 France Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 69 France Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 70 France Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 71 France Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 72 France Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 73 France Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 74 France Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 75 France Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 76 France Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 77 France Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 78 France Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 79 France Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 80 France Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 81 France Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 82 France Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 83 France Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 84 France Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 85 France Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 86 France Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 87 France Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 88 France Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 89 France Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 90 France Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 91 Italy Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 92 Italy Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 93 Italy Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 94 Italy Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 95 Italy Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 96 Italy Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 97 Italy Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 98 Italy Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 99 Italy Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 100 Italy Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 101 Italy Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 102 Italy Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 103 Italy Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 104 Italy Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 105 Italy Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 106 Italy Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 107 Italy Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 108 Italy Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 109 Italy Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 110 Italy Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 111 Italy Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 112 Italy Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 113 Italy Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 114 Italy Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 115 Italy Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 116 Italy Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 117 Italy Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 118 Italy Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 119 Italy Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 120 Italy Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 121 UK Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 122 UK Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 123 UK Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 124 UK Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 125 UK Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 126 UK Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 127 UK Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 128 UK Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 129 UK Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 130 UK Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 131 UK Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 132 UK Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 133 UK Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 134 UK Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 135 UK Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 136 UK Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 137 UK Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 138 UK Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 139 UK Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 140 UK Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 141 UK Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 142 UK Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 143 UK Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 144 UK Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 145 UK Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 146 UK Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 147 UK Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 148 UK Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 149 UK Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 150 UK Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 151 Spain Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 152 Spain Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 153 Spain Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 154 Spain Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 155 Spain Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 156 Spain Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 157 Spain Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 158 Spain Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 159 Spain Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 160 Spain Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 161 Spain Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 162 Spain Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 163 Spain Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 164 Spain Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 165 Spain Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 166 Spain Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 167 Spain Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 168 Spain Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 169 Spain Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 170 Spain Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 171 Spain Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 172 Spain Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 173 Spain Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 174 Spain Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 175 Spain Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 176 Spain Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 177 Spain Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 178 Spain Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 179 Spain Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 180 Spain Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by Global Data

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Hematological Malignancies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • November 2016
  • by Transparency Market Research

Hematological Malignancies Market: Overview This report provides in-depth region wise and country wise analysis of the hematological malignancies market. Stakeholders of this report include manufacturers ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.